Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers.

Literature DB >> 28975930

Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers.

Vinay Prasad¹.

Abstract

Mesh：

Substances：

Year: 2017 PMID： 28975930 DOI： 10.1038/nrclinonc.2017.156

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

× No keyword cloud information.

3 in total

1. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.

Authors: Vinay Prasad; Sham Mailankody
Journal: JAMA Intern Med Date: 2017-11-01 Impact factor: 21.873

2. Is patient travel distance associated with survival on phase II clinical trials in oncology?

Authors: Elizabeth B Lamont; Davinder Hayreh; Kate E Pickett; James J Dignam; Marcy A List; Kerstin M Stenson; Daniel J Haraf; Bruce E Brockstein; Sarah A Sellergren; Everett E Vokes
Journal: J Natl Cancer Inst Date: 2003-09-17 Impact factor: 13.506

3. Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database.

Authors: N S Majhail; L W Mau; E M Denzen; T J Arneson
Journal: Bone Marrow Transplant Date: 2012-07-09 Impact factor: 5.483

3 in total

60 in total

1. Scaffold-Mediated Static Transduction of T Cells for CAR-T Cell Therapy.

Authors: Pritha Agarwalla; Edikan A Ogunnaike; Sarah Ahn; Frances S Ligler; Gianpietro Dotti; Yevgeny Brudno
Journal: Adv Healthc Mater Date: 2020-06-11 Impact factor: 9.933

2. Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.

Authors: John W Hickey; Jonathan P Schneck
Journal: J Vis Exp Date: 2018-11-17 Impact factor: 1.355

3. Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies.

Authors: Sindhu Cherian; Maryalice Stetler-Stevenson
Journal: Curr Protoc Cytom Date: 2018-09-13

Review 4. Enabling Technologies for Personalized and Precision Medicine.

Authors: Dean Ho; Stephen R Quake; Edward R B McCabe; Wee Joo Chng; Edward K Chow; Xianting Ding; Bruce D Gelb; Geoffrey S Ginsburg; Jason Hassenstab; Chih-Ming Ho; William C Mobley; Garry P Nolan; Steven T Rosen; Patrick Tan; Yun Yen; Ali Zarrinpar
Journal: Trends Biotechnol Date: 2020-01-21 Impact factor: 19.536

Review 5. Biological Products: Cellular Therapy and FDA Approved Products.

Authors: Ali Golchin; Tahereh Zarnoosheh Farahany
Journal: Stem Cell Rev Rep Date: 2019-04 Impact factor: 5.739

6. Design of a Peptide-Based Electronegative Hydrogel for the Direct Encapsulation, 3D Culturing, in Vivo Syringe-Based Delivery, and Long-Term Tissue Engraftment of Cells.

Authors: Y Yamada; N L Patel; J D Kalen; J P Schneider
Journal: ACS Appl Mater Interfaces Date: 2019-09-13 Impact factor: 9.229